Dr. Leenu Mary Pallickal is a Austin, Texas based neurologist who is specialized in Neurology. Active license number of Dr. Leenu Mary Pallickal is BP10029779 for Neurology in Texas. Her current practice location is 601 E 15th St, Brack Annex Neurology Department, Austin. Patients can reach her at 512-324-7000 or can fax her at 512-324-8933. Dr. Leenu Mary Pallickal is M.D. in Neurology and her NPI number (Unique professional ID assigned by NPPES) is 1962681841. Dr. Leenu Mary Pallickal specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Leenu Mary Pallickal speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1962681841
NPI Enumeration Date:
29 Oct, 2007
NPI Last Update On:
29 Oct, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Leenu Mary Pallickal are as mentioned below.
License Number
Specialization
State
Status
BP10029779
Neurology
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Leenu Mary Pallickal 5800 Brodie Ln, Apt. 534 Austin, Texas
Zip:
78745-2557
Patients can reach Dr. Leenu Mary Pallickal at 601 E 15th St, Brack Annex Neurology Department, Austin, Texas or can call to book an appointment on 512-324-7000.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.